PERSPECTIVE THERAPEUTICS, INC.: basic weighted-average shares
Basic weighted-average shares for PERSPECTIVE THERAPEUTICS, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All PERSPECTIVE THERAPEUTICS, INC. financial histories
What this measure means
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
Exact concept: us-gaap:WeightedAverageNumberOfSharesOutstandingBasic. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2019-07-01 to 2025-12-31. The SEC response was captured on 2026-09-19.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 73,813,000 | shares | 2026-03-16 | 10-K · 0000728387-26-000004 |
| 2024-01-01 | 2024-12-31 | 64,425,000 | shares | 2026-03-16 | 10-K · 0000728387-26-000004 |
| 2023-01-01 | 2023-12-31 | 26,764,000 | shares | 2025-03-28 | 10-K/A · 0000950170-25-046758 |
| 2022-01-01 | 2022-12-31 | 142,067,000 | shares | 2024-03-28 | 10-K · 0001437749-24-009696 |
| 2021-07-01 | 2022-06-30 | 141,987,000 | shares | 2024-03-28 | 10-K · 0001437749-24-009696 |
| 2020-07-01 | 2021-06-30 | 103,841,000 | shares | 2022-09-28 | 10-K · 0001437749-22-023188 |
| 2019-07-01 | 2020-06-30 | 67,601,000 | shares | 2022-09-28 | 10-K · 0001437749-22-023188 |
Related financial histories
- PERSPECTIVE THERAPEUTICS, INC.: total assets
- PERSPECTIVE THERAPEUTICS, INC.: total liabilities
- PERSPECTIVE THERAPEUTICS, INC.: stockholders equity
- PERSPECTIVE THERAPEUTICS, INC.: cash and cash equivalents
- PERSPECTIVE THERAPEUTICS, INC.: net income or loss
- PERSPECTIVE THERAPEUTICS, INC.: operating cash flow
- PERSPECTIVE THERAPEUTICS, INC.: capital expenditure payments
- PERSPECTIVE THERAPEUTICS, INC.: revenue
- PERSPECTIVE THERAPEUTICS, INC.: financing cash flow
- PERSPECTIVE THERAPEUTICS, INC.: investing cash flow
- PERSPECTIVE THERAPEUTICS, INC.: retained earnings or deficit
- PERSPECTIVE THERAPEUTICS, INC.: diluted weighted-average shares
- PERSPECTIVE THERAPEUTICS, INC.: basic earnings per share
- PERSPECTIVE THERAPEUTICS, INC.: diluted earnings per share
- PERSPECTIVE THERAPEUTICS, INC.: income tax expense or benefit
- PERSPECTIVE THERAPEUTICS, INC.: net property, plant and equipment
- PERSPECTIVE THERAPEUTICS, INC.: share-based compensation expense
- PERSPECTIVE THERAPEUTICS, INC.: operating income or loss
- PERSPECTIVE THERAPEUTICS, INC.: current assets
- PERSPECTIVE THERAPEUTICS, INC.: interest expense
- PERSPECTIVE THERAPEUTICS, INC.: current liabilities
- PERSPECTIVE THERAPEUTICS, INC.: goodwill carrying amount
- PERSPECTIVE THERAPEUTICS, INC.: net finite-lived intangible assets
- PERSPECTIVE THERAPEUTICS, INC.: net current accounts receivable
- PERSPECTIVE THERAPEUTICS, INC.: operating expenses
- PERSPECTIVE THERAPEUTICS, INC.: net inventory
- PERSPECTIVE THERAPEUTICS, INC.: gross profit
- PERSPECTIVE THERAPEUTICS, INC.: research and development expense
Inspect the source
- Entity
- PERSPECTIVE THERAPEUTICS, INC. / CIK 0000728387
- Captured
- 2026-09-19T15:00:29.793Z
- SEC response SHA-256
80792777921b49454c9d29f110283a1024ec5ce2a3749610d4c1319da49650fe
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000728387.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))